Axsome Therapeutics Inc. will host its Frontiers in Brain Health R&D Day on July 21, 2025, in New York City. The event will showcase Axsome's innovative late-stage CNS pipeline, with discussions led by physician key opinion leaders covering the company's current indications in neurology and psychiatry. Members of the Axsome management team will also provide an overview of the clinical development programs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.